Funding & Support

Our research is supported by national and European funding agencies and programs, including the European Union (Horizon Europe, FP7, CHIST-ERA), the French National Research Agency (ANR), Inserm-ITMO Cancer, the French National Cancer Institute (INCa), and Cancéropôle Nord-Ouest (CNO).

2026-2030: ANR E-STIM: Autonomic Nervous System Evaluation for Sacral Neuromodulation Efficiency Prediction
2026-2028: INCa & IReSP: ADN-NOLO – noLo Alcool: Normative Dynamics, NoLo Practices, and Public Health Issues in France
2026-2027: CNO Emergence : Rôle de DACT1 dans les cellules cancéreuses de sein triples négatives
2025-2026: CHU Lille (Bonus H). BLCA-VALID : Validation externe d’une classification moléculaire universelle des cancers de vessie
2025-2029: INCa PLBIO MUCIN: Characterization of the MUC4-TRPM7 complex and associated cellular mechanisms. Identification of key regulators through spatial transcriptomics
2024-2028: INCa Siric Pediatric En-Hope Smart4cbt: East North-Hematology Oncology PEdiatric consortium offering a research program of Social sciences, Microenvironment and multiomics Analysis in RadioTherapy resistance For Children Brain Tumors.
2023-2027: ANR CMAS CAPS’UL - CAmpus Participatif en Santé numérique du site Universitaire de Lille
2022-2025: ANR AI_PhD@Lille
2022-2026: INCa PLBIO NETMET: Regulation network of the oncogene addiction triggers by MET receptor in lung cancer
2021-2025: EU Horizon 2020 Katy: Knowledge At the Tip of Your fingers: Clinical Knowledge for Humanity
2021-2025: ANR/FNR PRCI GREENER: Gene and Regulatory Elements Networks Involved in Rice Root Tissue Differentiation.
2018-2022: INCa PLBIO INTEGRIN: Systems biology of integrin inhibition-induced apoptosis for novel glioblastoma treatment
2015-2018: EU CHIST-ERA AdaLab: Adaptive « Automated Scientific Laboratory
2016-2019: EU Horizon 2020 CHASSY: From multi-scale modeling of biological network to engineering metabolic circuits in a biotechnology chassis
2015-2019: ITMO cancer/INSERM LIONs: Large-scale Integrative approach to unravel the relationships between differentiatiON and tumorigenesiS.
2014-16: ANR Ingénierie robuste et évolution dirigée de voies métaboliques synthétiques par intégration des approches génomique
2013-2014: PEPS CNRS CREPE: Comparaison de Réseaux de régulation par Enumération de PErturbations
2012-16: EU FP7 SYSCILIA: A system biology approach to dissect cilia function and its disruption in human genetic disease
2012-2015: INCa PLBIO INSIGht: Search for new therapeutic targets through the Identification of Networks Specifically altered during tumorIGenesis